2011年AAP尿路感染指南中的诊断与影像学建议是否适用于2月龄以下婴儿
该队列研究纳入2016至2018年因首次发热性尿路感染住院的≤24月龄患儿137例,比较<2月龄组与2至24月龄组的人口学、临床、尿液培养及影像学利用与结果。结果显示两组尿常规、尿培养及肾膀胱超声、排尿性膀胱尿道造影结果无差异;<2月龄组更常为男性且病情较轻。作者认为AAP指南的尿常规、尿培养诊断标准及普遍肾膀胱超声可安全应用于<2月龄婴儿,排尿性膀胱尿道造影推荐需进一步明确。
要点
- 2月龄以下婴儿的尿常规和尿培养结果与2至24月龄组无差异,支持沿用AAP诊断标准。
- 两组肾膀胱超声和排尿性膀胱尿道造影结果无差异,但2月龄以下组更常被推荐和完成排尿性膀胱尿道造影。
- 2月龄以下组男性比例更高(71.2% vs 43.6%,p=0.002),发热时间更短、最高体温更低、白细胞计数更低。
核心结论
- AAP指南中的实验室检测和肾膀胱超声建议可安全应用于2月龄以下婴儿;排尿性膀胱尿道造影的最佳推荐需进一步研究明确。
研究设计与样本
- 队列研究,纳入2016至2018年在一家儿童医院因首次发热性尿路感染住院的≤24月龄患儿137例,数据通过前瞻性生成的电子病历记录模板采集并补充回顾性病历审查。
诊断标准与关键数值
- 2月龄以下组与2至24月龄组的尿常规和尿培养结果无差异,支持将AAP指南的尿常规和尿培养诊断标准应用于2月龄以下婴儿。
- 两组肾膀胱超声和排尿性膀胱尿道造影结果无差异,支持将AAP指南的普遍肾膀胱超声建议应用于2月龄以下婴儿。
临床应用与阅片要点
- 作者认为AAP指南的尿常规和尿培养诊断标准及普遍肾膀胱超声可安全应用于2月龄以下婴儿。
- 作者指出排尿性膀胱尿道造影指南推荐的适用性需进一步明确。
局限性
- 原文指出排尿性膀胱尿道造影指南推荐的适用性需进一步明确。
- 原文结论指出需进一步研究以明确排尿性膀胱尿道造影的最佳推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: In 2011, the American Academy of Pediatrics (AAP) published guidelines regarding diagnosis and management of children 2-to-24-months-old with initial febrile urinary tract infection (fUTI). Available data were insufficient to determine whether evidence from studies of 2-to-24-month-olds applies to those <2-months-old, so they were excluded.
OBJECTIVE: This study aimed to 1) compare demographic, clinical, imaging and outcomes between patients <2-months-old and those 2-to-24-months-old hospitalized with fUTI, and 2) assess whether diagnostic and imaging recommendations of the AAP 2011 guidelines apply to those <2-months-old.
STUDY DESIGN: A cohort study of patients ≤24-months-old hospitalized at a children's hospital with fUTI from 2016 to 2018 was conducted. Data were collected via a prospectively generated electronic medical record note template, supplemented with retrospective chart review. Primary outcomes included differences in demographics, clinical presentation, urine culture results, and imaging utilization/results by age group. Secondary outcomes included surgical procedures, UTI recurrence, and 90-day all-cause readmissions and emergency department (ED) revisits. Univariate and bivariate statistics were utilized to compare age groups.
RESULTS: Overall, 137 patients were included (median age 70 days, 55.5% male [92.1% uncircumcised], 53.3% Hispanic/Latino, 89.8% 1st fUTI). There were no demographic differences between groups, except children <2-months-old were more frequently male (71.2 vs 43.6%, p = 0.002). The Summary Table compares clinical factors and imaging utilization by age. There were no differences in urinalysis or urine culture results between groups. Patients <2-months-old had shorter fever duration, lower maximum temperature, and lower white blood cell counts. Voiding cystourethrograms (VCUGs) were recommended and obtained more frequently in patients <2-months-old, but there were no differences in renal and bladder ultrasound (RBUS) or VCUG results between age groups. There were no differences in UTI recurrence (13.6% of <2-months-old vs 14.1% of 2-to-24-months-old, p = 1.00) or fUTI recurrence (13.6 vs 7.7%, p = 0.40) within 1 year, 90-day readmission (6.8 vs 6.4%, p = 1.00), or 90-day ED revisit (22.0 vs 20.5%, p = 1.00).
DISCUSSION: There were minimal differences between the <2-months-old and 2-to-24-months-old age groups in demographics, laboratory (including microbial) or imaging results, or clinical outcomes. Patients <2-months-old were more frequently male and less ill. These data support applying urinalysis and urine culture diagnostic criteria, and universal RBUS, from the AAP guidelines to patients <2-months-old. Given utilization differences, applicability of VCUG guideline recommendations requires further clarification for patients <2-months-old.
CONCLUSION: Laboratory testing and RBUS recommendations from the AAP guidelines may be safely applied to infants <2-months-old. Further studies are needed to clarify optimal VCUG recommendations.
引用
- Walton, Shannon, Rague, et al. Can diagnostic and imaging recommendations from the 2011 AAP UTI guidelines be applied to infants <2 months of age? J Pediatr Urol. 2022. PMID: 35781184. doi:10.1016/j.jpurol.2022.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。